These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 25931810)

  • 1. Paclitaxel attenuates renal interstitial fibroblast activation and interstitial fibrosis by inhibiting STAT3 signaling.
    Zhang L; Xu X; Yang R; Chen J; Wang S; Yang J; Xiang X; He Z; Zhao Y; Dong Z; Zhang D
    Drug Des Devel Ther; 2015; 9():2139-48. PubMed ID: 25931810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy.
    Pang M; Ma L; Gong R; Tolbert E; Mao H; Ponnusamy M; Chin YE; Yan H; Dworkin LD; Zhuang S
    Kidney Int; 2010 Aug; 78(3):257-68. PubMed ID: 20520592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy.
    Pang M; Kothapally J; Mao H; Tolbert E; Ponnusamy M; Chin YE; Zhuang S
    Am J Physiol Renal Physiol; 2009 Oct; 297(4):F996-F1005. PubMed ID: 19640900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Shenkang on renal fibrosis and activation of renal interstitial fibroblasts through the JAK2/STAT3 pathway.
    Qin T; Wu Y; Liu T; Wu L
    BMC Complement Med Ther; 2021 Jan; 21(1):12. PubMed ID: 33407391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repurposing paclitaxel for the treatment of fibrosis: indication discovery for existing drugs.
    Chen XW; Duan W; Zhou SF
    Drug Des Devel Ther; 2015; 9():4869-71. PubMed ID: 26379422
    [No Abstract]   [Full Text] [Related]  

  • 6. Src inhibition blocks renal interstitial fibroblast activation and ameliorates renal fibrosis.
    Yan Y; Ma L; Zhou X; Ponnusamy M; Tang J; Zhuang MA; Tolbert E; Bayliss G; Bai J; Zhuang S
    Kidney Int; 2016 Jan; 89(1):68-81. PubMed ID: 26444028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking sirtuin 1 and 2 inhibits renal interstitial fibroblast activation and attenuates renal interstitial fibrosis in obstructive nephropathy.
    Ponnusamy M; Zhou X; Yan Y; Tang J; Tolbert E; Zhao TC; Gong R; Zhuang S
    J Pharmacol Exp Ther; 2014 Aug; 350(2):243-56. PubMed ID: 24833701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of poly(ADP-ribose) polymerase 1 attenuates renal fibrosis and inflammation during unilateral ureteral obstruction.
    Kim J; Padanilam BJ
    Am J Physiol Renal Physiol; 2011 Aug; 301(2):F450-9. PubMed ID: 21613422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astragaloside IV inhibits renal tubulointerstitial fibrosis by blocking TGF-β/Smad signaling pathway in vivo and in vitro.
    Wang L; Chi YF; Yuan ZT; Zhou WC; Yin PH; Zhang XM; Peng W; Cai H
    Exp Biol Med (Maywood); 2014 Oct; 239(10):1310-24. PubMed ID: 24879422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukemia inhibitory factor attenuates renal fibrosis through Stat3-miR-29c.
    Yu Y; Wang Y; Niu Y; Fu L; Chin YE; Yu C
    Am J Physiol Renal Physiol; 2015 Oct; 309(7):F595-603. PubMed ID: 26155847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FTY720 ameliorates renal fibrosis by simultaneously affecting leucocyte recruitment and TGF-β signalling in fibroblasts.
    Tian T; Zhang J; Zhu X; Wen S; Shi D; Zhou H
    Clin Exp Immunol; 2017 Oct; 190(1):68-78. PubMed ID: 28658504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural flavonoid pectolinarigenin alleviated kidney fibrosis via inhibiting the activation of TGFβ/SMAD3 and JAK2/STAT3 signaling.
    Li Y; Guo F; Huang R; Ma L; Fu P
    Int Immunopharmacol; 2021 Feb; 91():107279. PubMed ID: 33340783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astragaloside IV synergizes with ferulic acid to inhibit renal tubulointerstitial fibrosis in rats with obstructive nephropathy.
    Meng LQ; Tang JW; Wang Y; Zhao JR; Shang MY; Zhang M; Liu SY; Qu L; Cai SQ; Li XM
    Br J Pharmacol; 2011 Apr; 162(8):1805-18. PubMed ID: 21232035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed administration of suramin attenuates the progression of renal fibrosis in obstructive nephropathy.
    Liu N; Tolbert E; Ponnusamy M; Yan H; Zhuang S
    J Pharmacol Exp Ther; 2011 Sep; 338(3):758-66. PubMed ID: 21622732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S3I-201 ameliorates tubulointerstitial lesion of the kidneys in MRL/lpr mice.
    Du Y; Zhang W; Liu S; Feng X; Gao F; Liu Q
    Biochem Biophys Res Commun; 2018 Sep; 503(1):177-180. PubMed ID: 29885836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of STAT3 acetylation is associated with angiotesin renal fibrosis in the obstructed kidney.
    Ni J; Shen Y; Wang Z; Shao DC; Liu J; Fu LJ; Kong YL; Zhou L; Xue H; Huang Y; Zhang W; Yu C; Lu LM
    Acta Pharmacol Sin; 2014 Aug; 35(8):1045-54. PubMed ID: 24976155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of Elp2 prevents renal fibrosis and inflammation induced by unilateral ureter obstruction (UUO) via inactivating Stat3-regulated TGF-β1 and NF-κB pathways.
    Lu S; Fan HW; Li K; Fan XD
    Biochem Biophys Res Commun; 2018 Jun; 501(2):400-407. PubMed ID: 29723529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat Shock Protein 72 Antagonizes STAT3 Signaling to Inhibit Fibroblast Accumulation in Renal Fibrogenesis.
    Zhou Y; Cao S; Li H; Peng X; Wang Y; Fan J; Wang Y; Zhuang S; Yu X; Mao H
    Am J Pathol; 2016 Apr; 186(4):816-28. PubMed ID: 26851345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of spleen tyrosine kinase (syk) suppresses renal fibrosis through anti-inflammatory effects and down regulation of the MAPK-p38 pathway.
    Chen KH; Hsu HH; Yang HY; Tian YC; Ko YC; Yang CW; Hung CC
    Int J Biochem Cell Biol; 2016 May; 74():135-44. PubMed ID: 26948651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STAT3 Inhibition Partly Abolishes IL-33-Induced Bone Marrow-Derived Monocyte Phenotypic Transition into Fibroblast Precursor and Alleviates Experimental Renal Interstitial Fibrosis.
    Zhu F; Bai X; Hong Q; Cui S; Wang X; Xiao F; Li J; Zhang L; Dong Z; Wang Y; Cai G; Chen X
    J Immunol; 2019 Nov; 203(10):2644-2654. PubMed ID: 31591147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.